ACE-041

Known as: ALK1-Fc Fusion Protein ACE-041, Activin Receptor-like Kinase 1 Inhibitor ACE-041 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2014
0120112014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Development of anti-angiogenic therapy including the vascular endothelial growth factor (VEGF) antibodies and VEGF-tyrosine… (More)
Is this relevant?
2014
2014
PURPOSE The angiogenesis inhibitor dalantercept (formerly ACE-041) is a soluble form of activin receptor-like kinase-1 (ALK1… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
30 Background: Activin receptor-like kinase 1 (ALK1) is a type 1 receptor in the TGF-β superfamily. The ALK1 pathway plays a role… (More)
Is this relevant?
2011
2011
3070 Background: Activin receptor-like kinase-1 (ALK1) is a type I receptor in the TGFß superfamily expressed on endothelial… (More)
Is this relevant?